Search - tctmd.com

Displaying 761 - 780 of 981

Sort: Relevancy | Date

News Daily News

Major Bleeds Late After TAVR Not Only Frequent But Portend Worse Outcomes

Todd Neale

December 16, 2014

News Daily News

采用Sapien 3经股动脉植入时，死亡率和卒中发生率均很低

December 04, 2014

News Daily News

PARTNER Registry Documents Strides Made in Transfemoral TAVR

L.A. McKeown

December 04, 2014

News Daily News

Low Mortality, Stroke With Transfemoral Implant of Sapien 3

December 04, 2014

News Daily News

Bajo Índice de Mortalidad y ACV con el Implante Transfemoral de Sapien 3

December 04, 2014

News Daily News

Sapien 3 Ups Need for Pacemaker Compared With Its Predecessor, But Reduces Moderate-Severe Paravalvular Leak

Todd Neale

December 04, 2014

News Daily News

Periprocedural TAVR Complications Common, Costly

L.A. McKeown

November 02, 2014

News Daily News

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

October 17, 2014

News Daily News

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

October 10, 2014

News Daily News

PARTNER Subanalysis Examines Effect of Annulus Size on Valve Hemodynamics, Outcomes

Yael L. Maxwell

October 10, 2014

News Daily News

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

October 03, 2014

Presentation TCT 2014

TCT 700: Multicenter Evaluation of Transcatheter Aortic Valve Replacement Using Either SAPIEN XT or CoreValve: Degree of Device Oversizing and Clinical Outcomes

Presenter: Danny Dvir

September 16, 2014

Presentation TCT 2014

TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Samir R. Kapadia

September 16, 2014

Presentation TCT 2014

Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Nicole Ibrahim

September 16, 2014

Presentation TCT 2014

TCT 694: Early Outcomes with Direct Flow Medical Versus First-Generation Transcatheter Aortic Valve Devices: A Single-Center, Propensity-Matched Analysis

Presenter: Thomas F. Luscher, Gennaro Giustino

September 16, 2014

Presentation TCT 2014

Novel Sheath Technology for TAVR

Presenter: Hemal Gada

September 15, 2014

Presentation TCT 2014

New Dedicated Guidewires for TAVR

Presenter: Wesley R. Pedersen

September 15, 2014

Presentation TCT 2014

Transcatheter-Based Homologous Off-the-Shelf Tissue Engineered Heart Valves with Self-Repair Capacity: Long-term Functionality and Rapid In Vivo Remodeling in Sheep

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Maximilian Y Emmert

September 15, 2014

Presentation TCT 2014

Landscape Highlights of New Transapical Access-Closure Devices

Presenter: Thomas Walther

September 15, 2014

Presentation TCT 2014

The Emboline Aortic Embolic Protection Technology

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Scott Russell

September 15, 2014

Advertisement

Major Bleeds Late After TAVR Not Only Frequent But Portend Worse Outcomes

采用Sapien 3经股动脉植入时，死亡率和卒中发生率均很低

PARTNER Registry Documents Strides Made in Transfemoral TAVR

Low Mortality, Stroke With Transfemoral Implant of Sapien 3

Bajo Índice de Mortalidad y ACV con el Implante Transfemoral de Sapien 3

Sapien 3 Ups Need for Pacemaker Compared With Its Predecessor, But Reduces Moderate-Severe Paravalvular Leak

Periprocedural TAVR Complications Common, Costly

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

PARTNER Subanalysis Examines Effect of Annulus Size on Valve Hemodynamics, Outcomes

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

TCT 700: Multicenter Evaluation of Transcatheter Aortic Valve Replacement Using Either SAPIEN XT or CoreValve: Degree of Device Oversizing and Clinical Outcomes

TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference?

Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future?

TCT 694: Early Outcomes with Direct Flow Medical Versus First-Generation Transcatheter Aortic Valve Devices: A Single-Center, Propensity-Matched Analysis

Novel Sheath Technology for TAVR

New Dedicated Guidewires for TAVR

Transcatheter-Based Homologous Off-the-Shelf Tissue Engineered Heart Valves with Self-Repair Capacity: Long-term Functionality and Rapid In Vivo Remodeling in Sheep

Landscape Highlights of New Transapical Access-Closure Devices

The Emboline Aortic Embolic Protection Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content